Zolmitriptan, sold under the brand name Zomig among others, is a triptan used in the acute treatment of migraine attacks with or without aura and cluster headaches. It is a selective serotonin receptor agonist of the 1B and 1D subtypes.
It was patented in 1990 and approved for medical use in 1997.
1 Medical uses
2 Adverse reactions
4 Mechanism of action
5.1 Brand names
6 Legal status
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions